Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune‐response induction in transplanted syngeneic rats

The hyperthermic effect of magnetic particles was examined in rat prostate cancer in vivo. Magnetic cationic liposomes (MCLs) have a positive surface charge and generate heat in an alternating magnetic field (AMF) due to hysteresis losses.

[1]  H. Honda,et al.  Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study. , 1996, Japanese journal of cancer research : Gann.

[2]  P. Wust,et al.  Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. , 1993, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[3]  C. Smart.  The results of prostate carcinoma screening in the U. S. As reflected in the surveillance, epidemiology, and end results program , 1997 .

[4]  Amnon Zisman,et al.  Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. , 2003, The Journal of urology.

[5]  Jun Yoshida,et al.  Intracellular Hyperthermia for Cancer Using Magnetite Cationic Liposomes: Ex vivo Study , 1996, Japanese journal of cancer research : Gann.

[6]  C. la Vecchia,et al.  Changed trends of cancer mortality in the elderly. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  J. Subjeck,et al.  Heat shock proteins and protection of proliferation and translation in mammalian cells. , 1984, Cancer research.

[8]  P. Schellhammer.  Editorial: Improving outcomes for primary and salvage therapy of localized prostate cancer. , 2003, The Journal of urology.

[9]  S D Prionas,et al.  Thermometry of interstitial hyperthermia given as an adjuvant to brachytherapy for the treatment of carcinoma of the prostate. , 1994, International journal of radiation oncology, biology, physics.

[10]  J. Lagendijk,et al.  Regional hyperthermia applicator design using FDTD modelling. , 2001, Physics in medicine and biology.

[11]  M. Tatematsu,et al.  Establishment and Characterization of Three Androgen‐independent, Metastatic Carcinoma Cell Lines from 3,2′‐Dimethyl‐4‐aminobiphenyl‐induced Prostatic Tumors in F344 Rats , 1996, Japanese journal of cancer research : Gann.

[12]  S. Ryu,et al.  Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia. , 1996, International journal of radiation oncology, biology, physics.

[13]  C. Owen,et al.  Magnetic labeling and cell sorting. , 1984, Journal of immunological methods.

[14]  J. J. de la Rosette,et al.  Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate , 2000, Journal of clinical pathology.

[15]  D. Xia,et al.  Potent antitumor effect elicited by superantigen‐linked tumor cells transduced with heat shock protein 70 gene , 2004, Cancer science.

[16]  Y. Yoshikai,et al.  V delta 5+ T cells of BALB/c mice recognize the murine heat shock protein 60 target cell specificity. , 1994, Immunology.

[17]  K. Kamiguchi,et al.  Tumor‐derived heat shock protein 70‐pulsed dendritic cells elicit tumor‐specific cytotoxic T lymphocytes (CTLs) and tumor immunity , 2004, Cancer science.

[18]  E. Gerner,et al.  Prospects for hyperthermia in human cancer therapy. Part II: implications of biological and physical data for applications of hyperthermia to man. , 1977, Radiology.

[19]  H. Honda,et al.  Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles , 2003, Cancer Immunology, Immunotherapy.

[20]  Y. Homma,et al.  Early results of LH-RH agonist treatment with or without chlormadinone acetate for hormone therapy of naive localized or locally advanced prostate cancer: a prospective and randomized study. The Prostate Cancer Study Group. , 2000, Japanese journal of clinical oncology.

[21]  A. Chang,et al.  Reduced efficacy of allogeneic versus syngeneic fibroblasts modified to secrete cytokines as a tumor vaccine adjuvant. , 1997, Cancer research.

[22]  M. McMahon,et al.  Hyperthermia and the heat-shock proteins of HeLa cells. , 1982, British Journal of Cancer.

[23]  Takeshi Kobayashi,et al.  Heat Properties of Magnetoliposomes for Local Hyperthermia , 1994 .

[24]  Y Lasne,et al.  Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results. , 1999, The Journal of urology.

[25]  G. Luyten,et al.  Effect of hyperthermia on expression of histocompatibility antigens and heat-shock protein molecules on three human ocular melanoma cell lines. , 1997, Melanoma research.

[26]  Z. Petrovich,et al.  Regional Hyperthermia in Patients with Recurrent Genitourinary Cancer , 1991, American journal of clinical oncology.

[27]  J. Battermann,et al.  Three-dimensional controlled interstitial hyperthermia combined with radiotherapy for locally advanced prostate carcinoma--a feasibility study. , 2002, International journal of radiation oncology, biology, physics.

[28]  D. Downey,et al.  Serial histopathology results of salvage cryoablation for prostate cancer after radiation failure. , 2003, The Journal of urology.

[29]  S Sutlief,et al.  Transperineal brachytherapy in patients with large prostate glands , 2000, International journal of cancer.

[30]  Olivier Rouvière,et al.  MRI Appearance of Prostate following Transrectal HIFU Ablation of Localized Cancer , 2001, European Urology.

[31]  M. Dewhirst,et al.  Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate. , 1997, International journal of radiation oncology, biology, physics.

[32]  M. D. Hurwitz, I. D. Kaplan, G. K. Svensson, M. S.,et al.  Feasibility and patient tolerance of a novel transrectal ultrasound hyperthermia system for treatment of prostate cancer , 2001 .

[33]  Y. Yoshikai,et al.  Vδ5+ T cells of BALB/c mice recognize the murine heat shock protein 60 target cell specificity , 1994 .

[34]  K. Hynynen,et al.  External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma , 2000, Cancer.

[35]  H. Honda,et al.  Antitumor Immunity Induction by Intracellular Hyperthermia Using Magnetite Cationic Liposomes , 1998, Japanese journal of cancer research : Gann.

[36]  P. Koutrouvelis,et al.  Prostate cancer with large glands treated with 3-dimensional computerized tomography guided pararectal brachytherapy: up to 8 years of followup. , 2003, The Journal of urology.

[37]  P. Littrup.  Future benefits and cost‐effectiveness of prostate carcinoma screening , 1997, Cancer.

[38]  R. Kiessling,et al.  Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells. , 2001, Cancer research.

[39]  Y. Nishimura,et al.  Development of intra-arterial hyperthermia using a dextran-magnetite complex. , 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[40]  K. Wallner,et al.  Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. , 2003, The Journal of urology.

[41]  Jun Yoshida,et al.  Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. , 1999, Japanese journal of cancer research : Gann.

[42]  S. Nakada,et al.  Cryoablation of renal and prostate tumors. , 2003, Journal of endourology.